8-K: iRhythm Holdings 2026 Annual Meeting Results

iRhythm Holdings stockholders approved the 2026 Equity Incentive Plan and ratified the appointment of KPMG LLP at the 2026 Annual Meeting.

Summary

• Stockholders approved the 2026 Equity Incentive Plan, which replaces the 2016 plan.
• All nine director nominees were elected to serve until the 2027 Annual Meeting.
• Stockholders approved the amendment to the Certificate of Incorporation to remove the pass-through voting provision.
• KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
• Executive compensation was approved on a non-binding advisory basis.
• The meeting achieved a quorum with 29,468,941 shares represented, or 89.69% of eligible shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine administrative filing reflecting successful corporate governance and shareholder alignment.

Positives

• High shareholder participation with 89.69% of eligible shares represented at the meeting.
• Strong support for the 2026 Equity Incentive Plan with 26,812,921 votes in favor.
• Overwhelming approval for the removal of the pass-through voting provision, simplifying corporate governance.
• Strong endorsement of the board of directors, with most nominees receiving over 26 million votes in favor.

Negatives

• Bruce Bodaken received a significant number of withheld votes (7,092,364) compared to other directors.

Risks

• Potential dilution of shareholder value resulting from the implementation of the new 2026 Equity Incentive Plan.
• Governance risks associated with executive compensation packages if they do not align with long-term performance.

Future Outlook

The company will operate under the newly approved 2026 Equity Incentive Plan and has confirmed its independent audit relationship with KPMG LLP through the end of the 2026 fiscal year.

Industry Context

StockSavvy.ai notes that the transition to new equity incentive plans is a standard corporate lifecycle event for growth-stage medical technology companies, aimed at retaining talent in a competitive labor market.

Comparison to Industry Standards

• The ratification of KPMG LLP is consistent with standard practices for NASDAQ-listed healthcare companies.
• The removal of pass-through voting provisions aligns with modern corporate governance trends favoring simplified capital structures.

Corporate Governance

Stakeholder Impact

• Shareholders benefit from simplified voting structures.
• Employees may be impacted by the new equity incentive plan terms.

Next Steps

• Implementation of the 2026 Equity Incentive Plan.
• Preparation for the 2027 Annual Meeting of Stockholders.

Key Dates

Keywords

iRhythm, IRTC, Annual Meeting, Equity Incentive Plan, Corporate Governance, Shareholder Voting